Catheter Precision updates selling stockholders in 68.1M-share resale prospectus after Creatd transfers preferred shares

Filed August 21, 2026 · ~1 min read

Key Changes

• high

  The prospectus covers resale of up to 68,067,042 shares of common stock by selling stockholders; the company receives no proceeds from these sales.

  The Offering view on EDGAR →
• medium

  Creatd transferred 3,870 Series D preferred shares to Anson Investments and 1,222 to Anson East, retaining 686 shares.

  The Offering view on EDGAR →
• medium

  Conversion of Series D preferred shares is based on a $0.35 floor price, affecting the number of common shares that may be sold.

  The Offering view on EDGAR →